Paper Review Records
All Paper Review Records
15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Modeling ethnic differences via drug-predicted clearance from chemical structures
Soyoka Tanihata; Akiko Watanabe; Koichi Handa; Hiroaki IwataShow moreShow less
Department of Biological Regulation, Faculty of Medicine, Tottori University, Japan; Teijin Institute for Bio-medical Research, Teijin Pharma Limited, Japan; Pharmacokinetics Laboratory, Non-clinical Development Department, Research & Development Division, Meiji Seika Pharma, Co., Ltd, JapanShow moreShow less
Evaluation of PRG4 mRNA-loaded polymeric nanoparticles in vitro and in vivo models of osteoarthritis
Katrin Agnes Muenzebrock; Kelly Warmink; Remei Escudero Franch; Daniela M.J. Koster; Mattie Rijker; Yeter Dilek; Jie Du; Adriano P. Pontes; Niels Eijkelkamp; Joris Bekkers; Jaap Rip; Laura B. Creemers; Jaqueline Lourdes RiosShow moreShow less
Department of Orthopedics, University Medical Center Utrecht, Utrecht, the Netherlands; 20Med Therapeutics BV, Leiden, the Netherlands; Center for Translational Immunology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Orthopedics, Diakonessenhuis Hospital, Utrecht, the NetherlandsShow moreShow less
The impact of systemic redistribution on cutaneous pharmacokinetic-based bioequivalence: An in vivo dermal open flow microperfusion study for lidocaine and prilocaine
Katrin I. Tiffner; Tannaz Ramezanli; Beate Boulgaropoulos; Thomas Birngruber; Manfred Bodenlenz; Bettina C. Lackner; Reingard Raml; Sam G. Raney; Frank SinnerShow moreShow less
Institute for Biomedical Research and Technologies (HEALTH), Joanneum Research Forschungsgesellschaft m.b.H, Neue Stiftingtalstrasse 2, Graz, 8010, Austria; Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA; Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz, 8036, AustriaShow moreShow less
Discovery of a ROS-responsive dual-activity hydrogen sulfide donor against myocardial ischemia reperfusion injury
Rong-Hong Zhang; Long-Fa Yang; Yi-Ying Lian; Jin-Feng Long; Hong-Fu Liu; Yong-Long Zhao; Shang-Gao Liao; Yong-Jun Li; Dan Yang; Meng ZhouShow moreShow less
State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), School of Pharmacy, Guizhou Medical University, Guian New District, Guizhou, 561113, PR China; Center for Tissue Engineering and Stem Cell Research, Key Laboratory of Regenerative Medicine of Guizhou Province, School of Basic Medical Sciences, Guizhou Medical University, Guian New District, Guizhou, 561113, PR ChinaShow moreShow less
Mechanistic characterization of norjuziphine–β-lactoglobulin nanocomplexes: Protein conformational remodeling governs encapsulation and therapeutic effects in human hepatocellular carcinoma cells
Qing Cen; Wei Wang; Jie Pan; Haibo He; Weifeng Teng; Jingzhi Wang; Zhibin BaiShow moreShow less
Department of General Surgery, Cixi People's Hospital, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China; Pingyang Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325400, China; Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China; Department of Radiotherapy Oncology, The First People's Hospital of Yancheng, Yancheng No.1 People's Hospital, Affiliated Hospital of Medical School, Nanjing University, Yancheng, 224000, ChinaShow moreShow less
The top-down Finite Time Pharmacokinetic (FTPK) models vis-a-vis the bottom-up PBPK models in early drug development
Panos Macheras; Nikos Alimpertis; Athanasios A. TsekourasShow moreShow less
Faculty of Pharmacy, Laboratory of Biopharmaceutics Pharmacokinetics, National and Kapodistrian University of Athens, Athens, Greece; Finite Absorption Time (F.A.T.) Laboratories, National and Kapodistrian University of Athens, Athens, Greece; Department of Chemistry, Laboratory of Physical Chemistry, National and Kapodistrian University of Athens, Athens, GreeceShow moreShow less
FAQ
How long does EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES take to review a manuscript?
As of 2026-11-13, CrushSCI has 15 complete review records for EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. The fastest paper went from submission to acceptance in 44 days (Synthesis and biological evaluation of 68Ga-DOTA-PLE: a Plectin-1-targeted radiotracer for PET/MR imaging of pancreatic cancer, received 2026-06-30, accepted 2026-08-13); the slowest took 205 days. The average is 109.9 days and the median is 120 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
